Because TP53 mutations are expected to be clonal and were all homozygous due to loss of heterozygosity (LOH) of the remaining wild-type allele (as determined in our subsequent allelic imbalance analyses), we used the mutant allele fraction of TP53 in each sample to estimate tumor purity. Here, TP53 is linked to neoplasm.